Free Trial
→ Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (From Banyan Hill Publishing) (Ad)tc pixel

Oxford BioMedica (OTCMKTS:OXBDF) Hits New 52-Week High - What's Next?

Written by MarketBeat
Updated August 20, 2025
Oxford BioMedica logo with Medical background

Key Points

  • Oxford BioMedica's shares reached a new 52-week high of $6.72 during trading on Friday, reflecting a significant increase from the previous close of $6.26.
  • The company specializes in advanced gene delivery systems through its LentiVector platform, aiming to address safety and delivery challenges in therapeutics.
  • The stock has demonstrated strong price performance, with a 50-day moving average of $5.02 and a 200-day moving average of $4.43.
  • Five stocks to consider instead of Oxford BioMedica.

Oxford BioMedica (OTCMKTS:OXBDF - Get Free Report) shares reached a new 52-week high during trading on Friday . The company traded as high as $6.72 and last traded at $6.72, with a volume of 520 shares. The stock had previously closed at $6.26.

Oxford BioMedica Price Performance

The company has a fifty day simple moving average of $5.19 and a two-hundred day simple moving average of $4.47.

Oxford BioMedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Recommended Stories

Should You Invest $1,000 in Oxford BioMedica Right Now?

Before you consider Oxford BioMedica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford BioMedica wasn't on the list.

While Oxford BioMedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.